Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.

Abstract

BACKGROUND:

Bladder cancer is a significant healthcare problem in the United States of America with a high recurrence rate. Early detection of bladder cancer is essential for removing the tumor with preservation of the bladder, avoiding metastasis and hence improving prognosis and long-term survival. The objective of this study was to analyze the presence of DEK protein in voided urine of bladder cancer patients as a urine-based bladder cancer diagnostic test.

METHODS:

We examined the expression of DEK protein by western blot in 38 paired transitional cell carcinoma (TCC) bladder tumor tissues and adjacent normal tissue. The presence of DEK protein in voided urine was analyzed by western blot in 42 urine samples collected from patients with active TCC, other malignant urogenital disease and healthy individuals.

RESULTS:

The DEK protein is expressed in 33 of 38 bladder tumor tissues with no expression in adjacent normal tissue. Based on our sample size, DEK protein is expressed in 100% of tumors of low malignant potential, 92% of tumors of low grade and in 71% of tumors of high grade. Next, we analyzed 42 urine samples from patients with active TCC, other malignant urogenital disease, non-malignant urogenital disease and healthy individuals for DEK protein expression by western blot analysis. We are the first to show that the DEK protein is present in the urine of bladder cancer patients. Approximately 84% of TCC patient urine specimens were positive for urine DEK.

CONCLUSION:

Based on our pilot study of 38 bladder tumor tissue and 42 urine samples from patients with active TCC, other malignant urogenital disease, non-malignant urogenital disease and healthy individuals; DEK protein is expressed in bladder tumor tissue and voided urine of bladder cancer patients. The presence of DEK protein in voided urine is potentially a suitable biomarker for bladder cancer and that the screening for the presence of DEK protein in urine can be explored as a noninvasive diagnostic test for bladder cancer.

• Authors: Antara Datta, Martin E Adelson, Yakov Mogilevkin, Eli Mordechai, Abraham A Sidi, Jason P Trama
• Journal: BMC cancer (BMC Cancer) Vol. 11 Pg. 234 (Jun 10 2011) ISSN: 1471-2407 [Electronic] England
• PMID: 21663673 (Publication Type: Journal Article)

Chemical References

• Biomarkers, Tumor
• Chromosomal Proteins, Non-Histone
• Dek protein, human
• Oncogene Proteins
• Poly-ADP-Ribose Binding Proteins

Topics

• Aged
• Aged, 80 and over
• Biomarkers, Tumor (metabolism, urine)
• Cell Line, Tumor
• Chromosomal Proteins, Non-Histone (metabolism, urine)
• Female
• Gene Expression Regulation, Neoplastic
• Humans
• Male
• Middle Aged
• Oncogene Proteins (metabolism, urine)
• Poly-ADP-Ribose Binding Proteins
• Urinary Bladder Neoplasms (diagnosis)